サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1701828

ポイントオブケア分子診断市場レポート：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、2025年～2033年

Point of Care Molecular Diagnostics Market Report by Product and Service, Technology, Application, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ポイントオブケア分子診断市場レポート：製品・サービス別、技術別、用途別、エンドユーザー別、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ポイントオブケア分子診断市場の世界市場規模は2024年に40億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに87億米ドルに達し、2025～2033年の成長率（CAGR）は8.78％になると予測しています。感染症の罹患率の増加とヘルスケア施設の急速な発展が、市場の成長を大きく後押ししています。

ポイントオブケア（POC）分子診断薬は、感染症の診断と検出のために医師が行う検査を指します。これには、血液学、妊娠、不妊、感染症、尿検査キット、心代謝およびグルコースモニタリング機器などが含まれます。POC分子診断法は、感染症、微小残存病変、消化器疾患の特定、ヘモグロビンや便潜血のモニタリング、薬剤や薬剤クラスの代謝能力判定などに広く用いられています。これらの検査は、より迅速な結果を提供し、誤治療に関連する合併症を減少させ、感染管理対策を改善します。その結果、POC分子診断法は病院、集中治療室（ICU）、研究機関、診療所、分散型検査室、在宅介護施設などで幅広く応用されています。

ポイントオブケア分子診断市場動向：

世界中で感染症の流行が増加しており、市場の見通しは明るいです。POC分子診断検査は、インフルエンザ、結核、ヒト免疫不全ウイルス（HIV）感染、クラミジア、肝炎などの感染症管理に広く使用されている費用対効果の高いソリューションです。加えて、COVID-19の蔓延を効果的に管理・抑制するためのPCR検査キットに対する需要の高まりも、成長を促す要因として作用しています。さらに、低コストでユーザーフレンドリーな高感度分子診断検査を開発するための小型化、ナノテクノロジー、マイクロ流体工学の採用が、市場成長の原動力となっています。さらに、ヘルスケアインフラの改善や分子診断能力の強化に向けた政府のさまざまなイニシアチブの実施は、市場成長にプラスの影響を与えています。その他にも、デオキシリボ核酸（DNA）シーケンシングの急速な進歩、先進的な治療・診断検査に関する意識の高まり、高齢者人口の増加、クラウド接続型POC診断技術の最近の開発動向などが、市場成長の原動力になると予測されています。

本レポートで扱う主な質問

  • 2024年の世界のポイントオブケア分子診断市場の市場規模は？
  • 2025年～2033年の世界のポイントオブケア分子診断市場の予想成長率は？
  • 世界のポイントオブケア分子診断市場を牽引する主要因は何か？
  • 世界のポイントオブケア分子診断市場に対するCOVID-19の影響は？
  • 世界のポイントオブケア分子診断市場の製品・サービス別内訳は？
  • 世界のポイントオブケア分子診断市場の技術別の内訳は？
  • 世界のポイントオブケア分子診断市場の用途別内訳は？
  • 世界のポイントオブケア分子診断市場における主要地域は？
  • 世界のポイントオブケア分子診断市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のポイントオブケア分子診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品・サービス別

  • アッセイとキット
  • 機器および分析装置
  • ソフトウェアとサービス

第7章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
  • 交配
  • DNA配列解析
  • マイクロアレイ
  • 等温核酸増幅技術（INAAT）
  • その他

第8章 市場内訳：用途別

  • 感染症
  • 腫瘍学
  • 血液学
  • 出生前検査
  • 内分泌学
  • その他

第9章 市場内訳：エンドユーザー別

  • 医師の診療所
  • 病院とICU
  • 調査機関
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Binx Health Inc.
    • Co-Diagnostics Inc.
    • F. Hoffmann-La Roche Ltd
    • Gene STAT Molecular Diagnostics LLC
    • Hemocue AB（Danaher Corporation）
    • Meridian Bioscience Inc.
    • Molbio Diagnostics Private Limited
    • Quidel Corporation
    • Siemens Healthcare GmbH（Siemens AG）
    • Thermo Fisher Scientific Inc.
    • Visby Medical Inc.
図表

List of Figures

  • Figure 1: Global: Point of Care Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point of Care Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Point of Care Molecular Diagnostics Market: Breakup by Product and Service (in %), 2024
  • Figure 5: Global: Point of Care Molecular Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Point of Care Molecular Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Point of Care Molecular Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Point of Care Molecular Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Point of Care Molecular Diagnostics (Assays and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Point of Care Molecular Diagnostics (Instruments and Analyzers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Point of Care Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Point of Care Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Point of Care Molecular Diagnostics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Point of Care Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Point of Care Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Point of Care Molecular Diagnostics (DNA sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Point of Care Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Point of Care Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Point of Care Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Point of Care Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Point of Care Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Point of Care Molecular Diagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Point of Care Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Point of Care Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Point of Care Molecular Diagnostics (Hematology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Point of Care Molecular Diagnostics (Hematology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Point of Care Molecular Diagnostics (Prenatal Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Point of Care Molecular Diagnostics (Endocrinology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Point of Care Molecular Diagnostics (Endocrinology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Point of Care Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Point of Care Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Point of Care Molecular Diagnostics (Physicians' Offices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Point of Care Molecular Diagnostics (Hospitals and ICUs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Point of Care Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Point of Care Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Point of Care Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Point of Care Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: North America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: North America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: United States: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: United States: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Canada: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Canada: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Asia-Pacific: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Asia-Pacific: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: China: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: China: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Japan: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Japan: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: India: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: India: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: South Korea: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: South Korea: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Australia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Australia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Indonesia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Indonesia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Europe: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Europe: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Germany: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Germany: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: France: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: France: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: United Kingdom: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: United Kingdom: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Italy: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Italy: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Spain: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Spain: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Russia: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Russia: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Latin America: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Latin America: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Brazil: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Brazil: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Mexico: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Mexico: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Others: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Others: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Middle East and Africa: Point of Care Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Middle East and Africa: Point of Care Molecular Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 95: Middle East and Africa: Point of Care Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 96: Global: Point of Care Molecular Diagnostics Industry: SWOT Analysis
  • Figure 97: Global: Point of Care Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 98: Global: Point of Care Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point of Care Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Product and Service (in Million USD), 2025-2033
  • Table 3: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Point of Care Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Point of Care Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Point of Care Molecular Diagnostics Market: Key Players
目次
Product Code: SR112025A6271

The global point of care molecular diagnostics market size reached USD 4.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.7 Billion by 2033, exhibiting a growth rate (CAGR) of 8.78% during 2025-2033. The increasing incidence of infectious diseases paired with rapid development in healthcare facilities is significantly driving the market growth.

Point-of-care (POC) molecular diagnostics refer to tests performed by physicians to diagnose and detect infectious diseases. It includes hematology, pregnancy, fertility, infectious diseases, urinalysis testing kits, and cardiometabolic and glucose monitoring devices. POC molecular diagnostics is widely used for identifying infectious agents, minimal residual disease, and gastrointestinal disorders, monitoring hemoglobin and fecal occult blood, and determining a patient's ability to metabolize a drug or drug class. These tests offer faster results, reduce complications associated with mistreatment, and improve infection control measures. As a result, POC molecular diagnostics finds extensive applications in hospitals, intensive care units (ICUs), research institutes, clinics, decentralized laboratories, and homecare facilities.

Point of Care Molecular Diagnostics Market Trends:

The increasing prevalence of infectious diseases across the globe is creating a positive outlook for the market. POC molecular diagnostic tests is a cost-effective solution widely used to manage infectious diseases, such as flu, tuberculosis, human immunodeficiency virus (HIV) infection, chlamydia, and hepatitis. Additionally, the rising demand for PCR test kits to effectively manage and control the spread of COVID-19 is acting as another growth-inducing factor. Furthermore, the adoption of miniaturization, nanotechnology, and microfluidics to develop low-cost, user-friendly, and highly sensitive molecular diagnostic tests is providing an impetus to the market growth. Moreover, the implementation of various government initiatives toward improving healthcare infrastructure and enhancing molecular diagnostic capabilities is positively influencing the market growth. Other factors, including rapid advancements in deoxyribonucleic acid (DNA) sequencing, rising awareness regarding advanced therapeutic and diagnostic tests, increasing geriatric population, and recent developments in cloud-connected POC diagnostic technologies, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product and Service:

  • Assays and Kits
  • Instruments and Analyzers
  • Software and Services

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • Hybridization
  • DNA sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Breakup by Application:

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Others

Breakup by End User:

  • Physicians' Offices
  • Hospitals and ICUs
  • Research Institutes
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Binx Health Inc., Co-Diagnostics Inc., F. Hoffmann-La Roche Ltd, Gene STAT Molecular Diagnostics LLC, Hemocue AB (Danaher Corporation), Meridian Bioscience Inc., Molbio Diagnostics Private Limited, Quidel Corporation, Siemens Healthcare GmbH (Siemens AG), Thermo Fisher Scientific Inc. and Visby Medical Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global point of care molecular diagnostics market in 2024?
  • 2.What is the expected growth rate of the global point of care molecular diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global point of care molecular diagnostics market?
  • 4.What has been the impact of COVID-19 on the global point of care molecular diagnostics market?
  • 5.What is the breakup of the global point of care molecular diagnostics market based on the product and service?
  • 6.What is the breakup of the global point of care molecular diagnostics market based on the technology?
  • 7.What is the breakup of the global point of care molecular diagnostics market based on application?
  • 8.What are the key regions in the global point of care molecular diagnostics market?
  • 9.Who are the key players/companies in the global point of care molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point of Care Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Assays and kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments and Analyzers
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reaction (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hematology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prenatal Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Endocrinology
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Physicians' Offices
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and ICUs
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Binx Health Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Co-Diagnostics Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 F. Hoffmann-La Roche Ltd
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Gene STAT Molecular Diagnostics LLC
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Hemocue AB (Danaher Corporation)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Meridian Bioscience Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Molbio Diagnostics Private Limited
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Quidel Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Siemens Healthcare GmbH (Siemens AG)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Visby Medical Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio